Sanctuary Advisors »

Context Therapeutics shares owned by Sanctuary Advisors

Quarter-by-quarter ownership of Context Therapeutics (CNTX) shares owned by Sanctuary Advisors from 13F filings

Historical chart of Sanctuary Advisors investment in Context Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Context Therapeutics held by Sanctuary Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Context Therapeutics by Sanctuary Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $51k 19k 2.62

More positions owned by Sanctuary Advisors

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds Growth Etf (VUG)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Alphabet Cap Stk Cl A (GOOGL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Value Etf (VTV)
Eli Lilly & Co. (LLY)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Ishares Tr S&p 500 Val Etf (IVE)
Exxon Mobil Corporation (XOM)
Meta Platforms Cl A (META)
Ishares Tr S&p 500 Grwt Etf (IVW)

View all positions for Sanctuary Advisors

Top funds holding Context Therapeutics

MPM Oncology Impact Management
Blue Owl Capital Holdings
Nextech Invest
Deep Track Capital
Soleus Capital Management
Octagon Capital Advisors
Avidity Partners Management
Franklin Resources
Vanguard Group
Vanguard Capital Management
TCG Crossover Management
Marshall Wace
Dr. Jeffrey R. Jay, M.D.
Millennium Management
Sio Capital Management

View all funds holding Context Therapeutics